NORSE BIOTECH AS

2406 ELVERUM

Finances

Share Ownership

Return on Equity

439,31 %

Current Ratio

0,28

Debt-to-Equity Ratio

−0

Key figures (NOK)	2022	2021	2020	2019
Revenue	160 000	0	0	56 000
Net Income	−1 151 000	−426 000	−167 000	544 000
Total Assets	2 845 000	2 554 000	2 165 000	2 038 000
Total Equity	−262 000	888 000	1 314 000	1 481 000

Income (NOK)	2022	2021	2020	2019
Revenue	160 000	0	0	56 000
Expenditure	1 303 000	644 000	271 000	−578 000
Operating Profit	−1 143 000	−643 000	−271 000	634 000
Financial Income	1 000	0	2 000	1 000
Financial Costs	9 000	1 000	23 000	2 000
Financial Balance	−8 000	−1 000	−21 000	−1 000
Earnings Before Tax	−1 151 000	−644 000	−291 000	633 000
Tax	0	−219 000	−125 000	88 000
Net Income	−1 151 000	−426 000	−167 000	544 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 968 000	1 899 000	1 771 000	1 207 000
Total Current Assets	877 000	655 000	394 000	831 000
Total Assets	2 845 000	2 554 000	2 165 000	2 038 000
Total Retained Equity	−1 567 000	−416 000	10 000	176 000
Total Equity	−262 000	888 000	1 314 000	1 481 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	3 108 000	1 666 000	851 000	557 000
Total Equity and Debt	2 845 000	2 554 000	2 165 000	2 038 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	160 000	0	0	56 000
Revenue	160 000	0	0	56 000
Cost of Goods Sold	0	0	0	179 000
Salary Costs	602 000	138 000	−156 000	−1 030 000
Depreciation	360 000	337 000	302 000	185 000
Impairment	0	0	0	0
Expenditure	1 303 000	644 000	271 000	−578 000
Operating Profit	−1 143 000	−643 000	−271 000	634 000
Financial Income	1 000	0	2 000	1 000
Financial Costs	9 000	1 000	23 000	2 000
Financial Balance	−8 000	−1 000	−21 000	−1 000
Dividends	0	0	0	0
Net Income	−1 151 000	−426 000	−167 000	544 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	1 543 000	1 876 000	1 771 000	1 207 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	426 000	23 000	0	0
Total Tangible Assets	426 000	23 000	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	1 968 000	1 899 000	1 771 000	1 207 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	441 000	91 000	120 000	549 000
Total Current Assets	877 000	655 000	394 000	831 000
Total Assets	2 845 000	2 554 000	2 165 000	2 038 000
Total Equity	−262 000	888 000	1 314 000	1 481 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	122 000	91 000	3 000	42 000
Unpaid Taxes	62 000	63 000	28 000	48 000
Dividends	0	0	0	0
Other Current Debt	2 923 000	1 512 000	820 000	468 000
Total Current Debt	3 108 000	1 666 000	851 000	557 000
Total Equity and Debt	2 845 000	2 554 000	2 165 000	2 038 000

Financial indicators	2022	2021	2020	2019
Return on Equity	439,31 %	−47,97 %	−12,71 %	36,73 %
Debt-to-Equity Ratio	−0	0	0	0
Operating Profit Margin	−714,38 %	-	-	1 132,14 %
Current Ratio	0,28	0,39	0,46	1,49
Quick Ratio	0,28	0,39	0,46	1,49
Equity Ratio	−0,09	0,35	0,61	0,73
Gross Profit Margin	100 %	-	-	−219,64 %